| Patent application number | Description | Published |
|---|
| 20090012019 | Methods and Compositions Related to TR4 - Disclosed are compositions and methods related to TR4 and aging. | 01-08-2009 |
| 20090282496 | Androgen Receptor Related Methods for Treating Bladder Cancer - Disclosed are compositions and methods for treating bladder cancer. | 11-12-2009 |
| 20090305980 | Methods and Compositions Related to TR4 - Disclosed are compositions and methods related to TR4 and cancer. | 12-10-2009 |
| 20100017900 | Prostate Epithelial Androgen Receptor Suppresses Prostate Growth and Tumor Invasion - Described herein is the generation of the first conditional knockout AR (pes-ARKO) mice that lack AR only in prostate epithelia. Additionally demonstrated herein, through AR gain- and loss-of-function experiments, are the novel growth and differentiation roles of epithelial AR within the normal and cancerous prostate cells. | 01-21-2010 |
| 20100048676 | Non-androgen dependent roles for androgen receptor in liver cancer - Disclosed are compositions and methods for modulating AR activity, such as non-androgen dependent AR activity. Also disclosed are compositions and methods for diagnosing beast cancer and for inhibiting liver cancer growth. In addition, disclosed are methods for identifying molecules that inhibit AR in non-androgen dependent ways. | 02-25-2010 |
| 20100197784 | NOVEL CURCUMIN ANALOGUES AND USES THEREOF - The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired. | 08-05-2010 |
| 20110028538 | METHODS AND COMPOSITIONS RELATED TO TR4 LIGAND - Disclosed are compositions and methods related to TR4 and aging. | 02-03-2011 |
| 20110177059 | PSA AND KLK2 AS THERAPEUTIC TARGETS AND MOLECULES INHIBITING PSA AND KLK2 - Disclosed herein are compositions and methods relating to prostate-specific antigen (PSA), KLK2 and androgen receptor. Further provided are methods and compositions for inhibiting PSA and/or KLK2 activity. Further provided are compositions and methods for treating or preventing cancer. | 07-21-2011 |
